Detection of Inducible Clindamycin Resistance in Beta-Hemolytic Streptococci by Using the CLSI Broth Microdilution Test and Erythromycin-Clindamycin Combinations

被引：8

作者：

Bowling, Jason E. ^{[2
]}

Owens, Aaron E. ^{[2
,3
]}

McElmeel, M. Leticia ^{[1
]}

Fulcher, Letitia C. ^{[1
]}

Herrera, Monica L. ^{[4
]}

Wickes, Brian L. ^{[4
]}

Jorgensen, James H. ^{[1
,2
]}

机构：

[1] Univ Texas Hlth Sci Ctr San Antonio, Dept Pathol, San Antonio, TX 78229 USA

[2] Univ Texas Hlth Sci Ctr San Antonio, Dept Med, San Antonio, TX 78229 USA

[3] Univ Texas Hlth Sci Ctr San Antonio, Univ Hosp, Med Serv, San Antonio, TX 78229 USA

[4] Univ Texas Hlth Sci Ctr San Antonio, Dept Microbiol, San Antonio, TX 78229 USA

来源：

JOURNAL OF CLINICAL MICROBIOLOGY | 2010年 / 48卷 / 06期

关键词：

GROUP-B; GROUP-A; GROUP-C; MECHANISMS; PYOGENES; SUSCEPTIBILITY; STAPHYLOCOCCI; PREVALENCE; SPAIN;

D O I：

10.1128/JCM.00663-10

中图分类号：

Q93 [微生物学];

学科分类号：

071005 ; 100705 ;

摘要：

This study assessed an erythromycin-clindamycin (ERY-CC) broth test for inducible CC resistance in beta-hemolytic streptococci. One hundred one isolates of groups A, B, C, F, and G were tested by the CLSI broth microdilution method. Combinations of 1 and 0.25 mu g/ml or 0.5 and 0.25 mu g/ml of ERY and CC, respectively, detected all inducible isolates.

引用

页码：2275 / 2277

页数：3

共 15 条

[1]

*CLIN LAB STAND I, 2009, M100S19 CLIN LAB STA

[2] Antibiotic susceptibility and mechanisms of erythromycin resistance in clinical isolates of Streptococcus agalactiae:: French multicenter study [J].

De Mouy, D ;

Cavallo, JD ;

Leclercq, R ;

Fabre, R .

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2001, 45 (08) :2400-2402

[3] Prevalence and mechanisms of erythromycin resistance in group a and group B Streptococcus:: Implications for reporting susceptibility results [J].

Desjardins, M ;

Delgaty, KL ;

Ramotar, K ;

Seetaram, C ;

Toye, B .

JOURNAL OF CLINICAL MICROBIOLOGY, 2004, 42 (12) :5620-5623

[4] Prevalence and mechanisms of erythromycin and clindamycin resistance in clinical isolates of β-haemolytic streptococci of Lancefield groups A, B, C and G in Seville, Spain [J].

Diaz, L. Merino ;

Torres Sanchez, M. J. ;

Aznar Martin, J. .

CLINICAL MICROBIOLOGY AND INFECTION, 2008, 14 (01) :85-87

[5] Mechanisms of resistance to macrolides and lincosamides: Nature of the resistance elements and their clinical implications [J].

Leclercq, R .

CLINICAL INFECTIOUS DISEASES, 2002, 34 (04) :482-492

[6] Inducible clindamycin resistance in staphylococci: Should clinicians and microbiologists be concerned? [J].

Lewis, JS ;

Jorgensen, JH .

CLINICAL INFECTIOUS DISEASES, 2005, 40 (02) :280-285

[7] Macrolide resistance in Streptococcus pyogenes: prevalence, resistance determinants, and emm types [J].

Michos, Athanasios G. ;

Bakoula, Chrysanthi G. ;

Braoudaki, Maria ;

Koutouzi, Foteini I. ;

Roma, Eleftheria S. ;

Pangalis, Anastasia ;

Nikolopoulou, Georgia ;

Kirikou, Elena ;

Syriopoulou, Vassiliki P. .

DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE, 2009, 64 (03) :295-299

[8] MLS resistance phenotypes and mechanisms in β-haemolytic group B, C and G Streptococcus isolates in La Rioja, Spain [J].

Portillo, A ;

Lantero, M ;

Olarte, I ;

Ruiz-Larrea, F ;

Torres, C .

JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2001, 47 (01) :115-116

[9] Investigation of inducible clindamycin and telithromycin resistance in isolates of β-hemolytic streptococci [J].

Raney, Patti M. ;

Tenover, Fred C. ;

Carey, Roberta B. ;

McGowan, John E., Jr. ;

Patel, Jean B. .

DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE, 2006, 55 (03) :213-218

[10] Macrolide resistance in Peptostreptococcus spp. mediated by ermTR:: Possible source of macrolide-lincosamide-streptogramin B resistance in Streptococcus pyogenes [J].

Reig, M ;

Galan, JC ;

Baquero, F ;

Perez-Diaz, JC .

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2001, 45 (02) :630-632

← 1 2 →